Merger Notification - Announcement according to § 10 Cartel Act

Johnson & Johnson; ABIOMED, Inc. - BWB/Z-6128 | Bundeswettbewerbsbehörde

Johnson & Johnson; ABIOMED, Inc.

BWB/Z-6128

18.11.2022

On 18.11.2022 the Austrian Federal Competition Authority was notified of the following merger:

Planned purchase process

Indirect acquisition of sole control over and a shareholding of 100% in ABIOMED, Inc.,Massachusetts, USA by Johnson & Johnson, New Jersey, USA.
Affected industry: Medical devices. Manufacturing of medical and dental devices and materials.

Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 16.12.2022.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 17.12.2022 .

back to list